Pain Management Drugs And Devices Market: Global Industry Size, Growth, Analysis, Outlook and Forecast 2016-2022
According to a recently published report the Pain Management Drugs And Devices Market was estimated to grow around $37.8 billion in 2015 and it is forecasted to reach around $50.76 billionat a CAGR of 4.3% during 2015-2022. The segmentation of pain management drugs and devices market is based on product type, drug class, and indication and by geography. The report on pain management drugs and devices market forecast 2015-2022 (by product type, drug class, and indication and geography) provides detailed summary as well as predictive analysis of the market.
Detailed study on this Report: http://www.briskinsights.com/report/pain-management-drugs-and-devices-market
Rising prevalence of chronic diseases in all over the world is a key driver for the pain management drugs and devices market. The main reason is increasing number of chronic pain disorders such as migraine, chronic back pain, cancer pain and others which is directly boosting the demand for pain management drugs and devices.There is an increasing focus on high investment by various end users industries due to increasing number of hospitals and rising favorable government initiatives which are expected to fuel the pain management drugs and devices market.The another major factor which drives the market is therising geriatric population which helps in increasing the demand forthis market.Thepain management drugs and devices market also helps in reducing the long stay of a patient in the hospital and act as a major driver for global pain management drugs and devices market.
These are the major factors which help in boosting the pain management drugs and devices market. Some of the challenges that are to be faced by the pain management drugs and devices market arestringent regulatory guidelines and lack of novel therapeutics for pain management which immensely affects the pain management drugs and device market globally. The major restraints of this market are high competition among key players and dearth of experienced and skilled personnel that directly impacts and hinders the growth rate of pain management drugs and devices market.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/healthcare-market
Scope of the report
GlobalPain Management Drugs And DevicesMarketBy Product Type2012 - 2022 ($ Billion)
1.1. Electrical stimulation devices
1.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
1.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
1.1.3. Other Electrical Stimulation Devices
1.1.3.1. Electrotherapy Devices
1.1.3.2. Combination Devices
1.1.3.3. TNS
1.1.3.4. TMS
1.2. Radiofrequency ablation devices
1.3. Analgesic infusion pumps
1.3.1. Intrathecal Infusion Pumps
1.3.2. External Infusion Pumps
1.4. Neuro-stimulation devices
1.4.1. Spinal Cord Stimulation (SCS) Devices
1.4.2. Deep Brain Stimulation Devices
1.4.3. Vagus Nerve Stimulation Devices
1.4.4. Sacral Nerve Stimulation Devices
Global Pain Management DrugsAnd DevicesMarketBy Drug Class 2012 - 2022 ($ Billion)
2.1.1. NSAIDS
2.1.2. Anesthetics
2.1.3. Anticovulsants
2.1.4. Anti-Migraine Agents
2.1.5. Antidepressent
2.1.6. Opioids
2.1.7. Non-Narcotic Analgesics
Global Pain Management DrugsAnd DevicesMarket By Indications 2012 - 2022 ($ Billion)
3.1. Arthritic pain
3.2. Neuropathic pain
3.3. Cancer pain’
3.4. Chronic back pain
3.5. Post-operative pain
3.6. Migraine
3.7. Fibromyalgia
Global Pain Management DrugsAnd Devices MarketRegional Outlook 2012-2022 ($ Billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest Of The World
Company Profile
5.1. AstraZeneca PLC
5.2. Baxter International Inc.
5.3. Boston Scientific Corporation
5.4. Eli Lilly
5.5. Endo Health Solutions
5.6. Forest Laboratories
5.7. Halyard Inc.
5.8. Johnson & Johnson
5.9. Medtronic plc
5.10. Pfizer Inc
5.11. Purdue Pharma
5.12. Smiths Medical
5.13. St. Jude Medical
5.14. Stryker Corporation
5.15. Teva Pharmaceuticals (Cephalon, Inc.)
Blog: http://www.pdfdevices.com/global-pain-management-drugs-and-devices-market-is-expected-to-reach-50-76-billion-by-2022-brisk-insights/
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)
Email : sales@briskinsights.com
Website : http://www.briskinsights.com/
Detailed study on this Report: http://www.briskinsights.com/report/pain-management-drugs-and-devices-market
Rising prevalence of chronic diseases in all over the world is a key driver for the pain management drugs and devices market. The main reason is increasing number of chronic pain disorders such as migraine, chronic back pain, cancer pain and others which is directly boosting the demand for pain management drugs and devices.There is an increasing focus on high investment by various end users industries due to increasing number of hospitals and rising favorable government initiatives which are expected to fuel the pain management drugs and devices market.The another major factor which drives the market is therising geriatric population which helps in increasing the demand forthis market.Thepain management drugs and devices market also helps in reducing the long stay of a patient in the hospital and act as a major driver for global pain management drugs and devices market.
These are the major factors which help in boosting the pain management drugs and devices market. Some of the challenges that are to be faced by the pain management drugs and devices market arestringent regulatory guidelines and lack of novel therapeutics for pain management which immensely affects the pain management drugs and device market globally. The major restraints of this market are high competition among key players and dearth of experienced and skilled personnel that directly impacts and hinders the growth rate of pain management drugs and devices market.
For Same Category Reports Visit Here: http://www.briskinsights.com/category/healthcare-market
Scope of the report
GlobalPain Management Drugs And DevicesMarketBy Product Type2012 - 2022 ($ Billion)
1.1. Electrical stimulation devices
1.1.1. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
1.1.2. Neuromuscular Electrical Stimulation (NMES/EMS) Devices
1.1.3. Other Electrical Stimulation Devices
1.1.3.1. Electrotherapy Devices
1.1.3.2. Combination Devices
1.1.3.3. TNS
1.1.3.4. TMS
1.2. Radiofrequency ablation devices
1.3. Analgesic infusion pumps
1.3.1. Intrathecal Infusion Pumps
1.3.2. External Infusion Pumps
1.4. Neuro-stimulation devices
1.4.1. Spinal Cord Stimulation (SCS) Devices
1.4.2. Deep Brain Stimulation Devices
1.4.3. Vagus Nerve Stimulation Devices
1.4.4. Sacral Nerve Stimulation Devices
Global Pain Management DrugsAnd DevicesMarketBy Drug Class 2012 - 2022 ($ Billion)
2.1.1. NSAIDS
2.1.2. Anesthetics
2.1.3. Anticovulsants
2.1.4. Anti-Migraine Agents
2.1.5. Antidepressent
2.1.6. Opioids
2.1.7. Non-Narcotic Analgesics
Global Pain Management DrugsAnd DevicesMarket By Indications 2012 - 2022 ($ Billion)
3.1. Arthritic pain
3.2. Neuropathic pain
3.3. Cancer pain’
3.4. Chronic back pain
3.5. Post-operative pain
3.6. Migraine
3.7. Fibromyalgia
Global Pain Management DrugsAnd Devices MarketRegional Outlook 2012-2022 ($ Billion)
4.1. North America
4.2. Europe
4.3. Asia Pacific
4.4. Rest Of The World
Company Profile
5.1. AstraZeneca PLC
5.2. Baxter International Inc.
5.3. Boston Scientific Corporation
5.4. Eli Lilly
5.5. Endo Health Solutions
5.6. Forest Laboratories
5.7. Halyard Inc.
5.8. Johnson & Johnson
5.9. Medtronic plc
5.10. Pfizer Inc
5.11. Purdue Pharma
5.12. Smiths Medical
5.13. St. Jude Medical
5.14. Stryker Corporation
5.15. Teva Pharmaceuticals (Cephalon, Inc.)
Blog: http://www.pdfdevices.com/global-pain-management-drugs-and-devices-market-is-expected-to-reach-50-76-billion-by-2022-brisk-insights/
About Us :
Brisk Insights is a global market research firm. Our insightful analysis is focused on developed and emerging markets. We identify trends and forecast markets with a view to aid businesses identify market opportunities optimize strategies.
Working in a highly dynamic and multi-dimensional business makes decision making complex. Effective business decisions are a result of the synthesis of market information. Our Research and data analysis is an efficient and cost-effective way of providing robust market analysis and can yield highly valuable intelligence relating to consumers, competitors and markets.
Contact Us :
Jennifer Smith
Office 1094
109 Vernon House
Friar Lane
Nottingham
NG1 6DQ
United Kingdom
Phone : +448081890034 (UK)
Email : sales@briskinsights.com
Website : http://www.briskinsights.com/